Alterations of chylomicron metabolism during hypertension treatment (1991)
- Authors:
- USP affiliated authors: MACHADO, MARCELLO MARCONDES - FM ; QUINTAO, EDER CARLOS ROCHA - FM ; HEIMANN, JOEL CLAUDIO - FM ; BERNIK, MARCIA MARTINS SILVEIRA - HU
- Unidades: FM; HU
- Assunto: ENDOCRINOLOGIA
- Language: Inglês
- Source:
- Título: Hypertension
- Volume/Número/Paginação/Ano: v.17, n.3 , p.409, mar. 1991
- Conference titles: Scientific Meeting of the Inter-American Society of Hypertension
-
ABNT
BERNIK, M M S et al. Alterations of chylomicron metabolism during hypertension treatment. Hypertension. [S.l.]: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 20 out. 2024. , 1991 -
APA
Bernik, M. M. S., Heimann, J. C., Nakandakare, E. R., Neves, M. Q. T. S., Marcondes, M., & Quintão, E. C. da R. (1991). Alterations of chylomicron metabolism during hypertension treatment. Hypertension. Faculdade de Medicina, Universidade de São Paulo. -
NLM
Bernik MMS, Heimann JC, Nakandakare ER, Neves MQTS, Marcondes M, Quintão EC da R. Alterations of chylomicron metabolism during hypertension treatment. Hypertension. 1991 ;17( 3 ): 409.[citado 2024 out. 20 ] -
Vancouver
Bernik MMS, Heimann JC, Nakandakare ER, Neves MQTS, Marcondes M, Quintão EC da R. Alterations of chylomicron metabolism during hypertension treatment. Hypertension. 1991 ;17( 3 ): 409.[citado 2024 out. 20 ] - Metabolismo de emulsoes ricas em triglycerides em pacientes hipertensos tratados com dihidroclorotiazida ou propranolol
- Drug effects on the metabolism of artificial triglyceride rich emulsion particles resembling chylomicrons
- Reduction of lipid and CETP plasma concentrations by dietary plant sterol ester treatment in moderate hypercholesterolemia does not relate to the TAQ1B CETP polymorphism
- Bezafibrate modifies lipoprotein composition differently in patients with hypercholesterolemia and in patients with combined hyperlipidemia
- Long term treatment of hypercholesterolemia with simvastatin
- Ldl-apheresis in the treatment of one patient with homozygous familial hypercholesterolemia
- Fitoesterol esterificado na dieta diminui a concentração plasmática de colesterol e de CETP relacionada ao polimorfismo 1405V da CETP
- Effects of hydrochlorothiazide and propanolol treatment on chylomicron metabolism in hypertensive subjects
- Plasma cholesterol and CETP concentrations are lowered by dietary phytosterol ester but only the cholesterol variation related to the CETP 1405V polymorphism
- Reduction of lipid and CETP plasma concentrations by dietary plant sterol ester treatment in moderate hypercholesterolemia does not relate to the TAQ1B CETP polymorphism
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
